GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Level Bio AB (NGM:LEVBIO) » Definitions » COGS-to-Revenue

Level Bio AB (NGM:LEVBIO) COGS-to-Revenue : 0.42 (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Level Bio AB COGS-to-Revenue?

Level Bio AB's Cost of Goods Sold for the three months ended in Dec. 2024 was kr3.11 Mil. Its Revenue for the three months ended in Dec. 2024 was kr7.45 Mil.

Level Bio AB's COGS to Revenue for the three months ended in Dec. 2024 was 0.42.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Level Bio AB's Gross Margin % for the three months ended in Dec. 2024 was 58.27%.


Level Bio AB COGS-to-Revenue Historical Data

The historical data trend for Level Bio AB's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Level Bio AB COGS-to-Revenue Chart

Level Bio AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.61 0.59 0.56 0.53 0.46

Level Bio AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.64 0.48 0.49 0.48 0.42

Level Bio AB COGS-to-Revenue Calculation

Level Bio AB's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=11.602 / 25.096
=0.46

Level Bio AB's COGS to Revenue for the quarter that ended in Dec. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=3.109 / 7.45
=0.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Level Bio AB  (NGM:LEVBIO) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Level Bio AB's Gross Margin % for the three months ended in Dec. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 3.109 / 7.45
=58.27 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Level Bio AB COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Level Bio AB's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Level Bio AB Business Description

Traded in Other Exchanges
N/A
Address
Vastra Finnbodavagen 4B, Nacka, Stockholm, SWE, 131 30
Level Bio AB is a parent company and operates through subsidiary. It develops and manufactures diagnostic kits for the clinical market and also is a distributor and full service partner to molecular biology labs in the Nordics.

Level Bio AB Headlines

No Headlines